Results

Total Results: over 10,000 records

Showing results for "analyzed".

  1. srdr.ahrq.gov/projects/1542/studies/186813
    January 01, 2018 - Opioid-containing Analgesics: Codeine 24 hours N Analyzed 34 … Opioid-containing Analgesics: Codeine 24 hours N Analyzed 34 … Opioid-containing Analgesics: Codeine 0 N/A N Analyzed 34 … Opioid-containing Analgesics: Codeine 0 N/A N Analyzed 34 … Opioid-containing Analgesics: Codeine 24 hours N Analyzed 34
  2. srdr.ahrq.gov/projects/1565/studies/188323
    January 01, 2016 - Point Measure CPAP No CPAP Enter a numeric value or title (required) years N Analyzed … Point Measure CPAP No CPAP Enter a numeric value or title (required) years N Analyzed … Point Measure CPAP No CPAP Enter a numeric value or title (required) years N Analyzed … Point Measure CPAP No CPAP Enter a numeric value or title (required) years N Analyzed … 5.5 SD 1.9 1 years N Analyzed
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-e-surveillance-report-1_0.xlsx
    November 22, 2021 - Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed
  4. srdr.ahrq.gov/projects/1520/studies/186139
    January 01, 2010 - Antibiotic: Ertapenem 1 years N Analyzed 39 49 P-Value N.S … Antibiotic: Ertapenem 1 years N Analyzed 40 48 P-Value N.S … Antibiotic: Ertapenem 1 years N Analyzed 40 48 P-Value N.S … Antibiotic: Ertapenem 1 years N Analyzed 43 48 P-Value N.S … Antibiotic: Ertapenem 1 years N Analyzed 43 48 P-Value N.S
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed
  6. srdr.ahrq.gov/projects/1520/studies/186797
    January 15, 2021 - Participants Time Point Measure Elective surgery Elective surgery Elective surgery 30 days N Analyzed … Elective surgery Elective surgery Elective surgery Enter a numeric value or title (required) years N Analyzed … Elective surgery Elective surgery Elective surgery Enter a numeric value or title (required) years N Analyzed … Elective surgery Elective surgery Elective surgery Enter a numeric value or title (required) years N Analyzed … Elective surgery Elective surgery Elective surgery Enter a numeric value or title (required) years N Analyzed
  7. srdr.ahrq.gov/projects/1565/studies/188518
    January 01, 2016 - All Participants Time Point Measure CPAP No CPAP >=2 and <=7 years N Analyzed … Population: PCI Time Point Measure CPAP No CPAP >=2 and <=7 years N Analyzed … All Participants Time Point Measure CPAP No CPAP >=2 and <=7 years N Analyzed … Population: PCI Time Point Measure CPAP No CPAP >=2 and <=7 years N Analyzed … All Participants Time Point Measure CPAP No CPAP >=2 and <=7 years N Analyzed
  8. srdr.ahrq.gov/projects/1520/studies/186827
    January 01, 2017 - Participants Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … Hinchey Ia Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … Hinchey ≥Ib Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … Hinchey Ia Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … Hinchey ≥Ib Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed
  9. srdr.ahrq.gov/projects/1520/studies/186841
    January 01, 2014 - Healthy controls Enter a numeric value or title (required) years N Analyzed 149 … Healthy controls Diverticulitis without colonoscopy Enter a numeric value or title (required) years N Analyzed … Healthy controls Diverticulitis without colonoscopy Enter a numeric value or title (required) years N Analyzed … Healthy controls Enter a numeric value or title (required) years N Analyzed 149 … Healthy controls Enter a numeric value or title (required) years N Analyzed 149
  10. srdr.ahrq.gov/projects/1520/studies/186839
    January 01, 2019 - Antibiotics: Multiple (discretionary or undefined) 30 days N Analyzed 18 18 … Antibiotics: Multiple (discretionary or undefined) 30 days N Analyzed 18 18 … Antibiotics: Multiple (discretionary or undefined) 30 days N Analyzed 12 12 … IR: Percutaneous drainage 30 days N Analyzed 12 12 P-Value … Antibiotics: Multiple (discretionary or undefined) During initial admission N/A N Analyzed 18
  11. srdr.ahrq.gov/projects/1312/studies/175439
    January 01, 2003 - Comments ( 0 ) | Post/View n Analyzed … All Participants Time Point Measure Exposure 1 Control 1 0 weeks N Analyzed … 12 8 SE 4 weeks N Analyzed … All Participants Time Point Measure Exposure 1 Control 1 0 weeks N Analyzed … 13 9 SE 4 weeks N Analyzed
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed … Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed
  14. srdr.ahrq.gov/projects/1565/studies/189001
    January 01, 2016 - No CPAP 6 months N Analyzed 151 147 … No CPAP 6 months N Analyzed 151 147 … No CPAP 6 months N Analyzed 151 147 … No CPAP 6 months N Analyzed 151 147 … No CPAP 6 months N Analyzed 151 147
  15. srdr.ahrq.gov/projects/1542/studies/186850
    January 01, 1995 - Therapies: Thermal biofeedback, and Behavioral therapies: Relaxation Baseline N/A N Analyzed … Therapies: Thermal biofeedback, and Behavioral therapies: Relaxation Baseline N/A N Analyzed … Therapies: Thermal biofeedback, and Behavioral therapies: Relaxation Baseline N/A N Analyzed … 0.45 SD 0.77 Perinatal N/A N Analyzed … Mean 0.45 SD 3 months postnatal N/A N Analyzed
  16. srdr.ahrq.gov/projects/1520/studies/186820
    January 01, 2016 - )      Population: All Participants Time Point Measure Elective surgery 30 days N Analyzed … )      Population: All Participants Time Point Measure Elective surgery 30 days N Analyzed … )      Population: All Participants Time Point Measure Elective surgery 30 days N Analyzed … )      Population: All Participants Time Point Measure Elective surgery 30 days N Analyzed … (CD III)      Population: BMI 30-35 Time Point Measure Elective surgery 30 days N Analyzed
  17. srdr.ahrq.gov/projects/1520/studies/189216
    January 01, 2013 - Point Measure Placebo Pharm: 5-ASA Pharm: Mesalamine + Probiotic Comparison Measure 12 weeks N Analyzed … 5 4.248 Percentage 20 12.5 11.8 52 weeks N Analyzed … Participants Time Point Measure Placebo Pharm: 5-ASA Pharm: Mesalamine + Probiotic 12 weeks N Analyzed … Placebo 52 weeks N Analyzed 29 32 27 P-Value … ERROR 52 weeks N Analyzed 29 32 27 P-Value NS
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plant-based-treatments-draft-report-2025-rct-table-app-e.xlsx
    January 01, 2025 - for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed
  19. srdr.ahrq.gov/projects/1565/studies/188958
    January 01, 2012 - Population: All Participants Time Point Measure No CPAP CPAP 4 years N Analyzed … Population: All Participants Time Point Measure No CPAP CPAP 4 years N Analyzed … Population: All Participants Time Point Measure No CPAP CPAP 4 years N Analyzed … No CPAP 4 years N Analyzed 366 357 … No CPAP 4 years N Analyzed 3 8 Incidence
  20. srdr.ahrq.gov/projects/1520/studies/186816
    January 01, 2002 - Pharm: Rifaximin 3 months N Analyzed 109 109 P-Value <0.005 … Counts 42 19 Percentage 38.53 17.43 6 months N Analyzed … Pharm: Rifaximin 12 months N Analyzed 109 109 P-Value <0.01 … Pharm: Rifaximin 3 months N Analyzed 109 109 P-Value <0.005 … All Participants Time Point Measure Pharm: 5-ASA + Rifaximin Pharm: Rifaximin 12 months N Analyzed